Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 2
2010 1
2011 2
2012 2
2013 2
2016 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Cervical cancer screening in immigrant women in Italy: a survey on participation, cytology and histology results.
Campari C, Fedato C, Iossa A, Petrelli A, Zorzi M, Anghinoni E, Bietta C, Brachini A, Brezzi S, Cogo C, Giordano L, Giorgi D, Palazzi M, Petrella M, Schivardi MR, Visioli CB, Giorgi Rossi P; GISCi Migrant Working Group. Campari C, et al. Among authors: brezzi s. Eur J Cancer Prev. 2016 Jul;25(4):321-8. doi: 10.1097/CEJ.0000000000000173. Eur J Cancer Prev. 2016. PMID: 26207563
Knowledge, attitude and practice in primary and secondary cervical cancer prevention among young adult Italian women.
Donati S, Giambi C, Declich S, Salmaso S, Filia A, Ciofi degli Atti ML, Alibrandi MP, Brezzi S, Carozzi F, Collina N, Franchi D, Lattanzi A, Meda M, Minna MC, Nannini R, Gallicchio G, Bella A; PreGio Working group. Donati S, et al. Among authors: brezzi s. Vaccine. 2012 Mar 9;30(12):2075-82. doi: 10.1016/j.vaccine.2012.01.057. Epub 2012 Jan 31. Vaccine. 2012. PMID: 22300719
HPV testing is an efficient management choice for women with inadequate liquid-based cytology in cervical cancer screening.
Giorgi Rossi P, Carozzi F, Collina G, Confortini M, Dalla Palma P, De Lillo M, Del Mistro A, Ghiringhello B, Gillio-Tos A, Maioli P, Pellegrini A, Schiboni ML, Segnan N, Zaffina LM, Zorzi M, Ronco G; NTCC Working Group. Giorgi Rossi P, et al. Am J Clin Pathol. 2012 Jul;138(1):65-71. doi: 10.1309/AJCP6J2OEFOYTRFD. Am J Clin Pathol. 2012. PMID: 22706859 Clinical Trial.
Estimated acceptance of HPV vaccination among Italian women aged 18-26 years.
Giambi C, Donati S, Declich S, Salmaso S, Ciofi Degli Atti ML, Alibrandi MP, Brezzi S, Carozzi F, Collina N, Franchi D, Lattanzi A, Meda M, Minna MC, Nannini R, Scherillo I, Bella A; PreGio Working Group. Giambi C, et al. Among authors: brezzi s. Vaccine. 2011 Oct 26;29(46):8373-80. doi: 10.1016/j.vaccine.2011.08.079. Epub 2011 Aug 26. Vaccine. 2011. PMID: 21872630
HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology.
Ronco G, Cuzick J, Segnan N, Brezzi S, Carozzi F, Folicaldi S, Dalla Palma P, Del Mistro A, Gillio-Tos A, Giubilato P, Naldoni C, Polla E, Iossa A, Zorzi M, Confortini M, Giorgi-Rossi P; NTCC working group. Ronco G, et al. Among authors: brezzi s. Eur J Cancer. 2007 Feb;43(3):476-80. doi: 10.1016/j.ejca.2006.11.013. Epub 2007 Jan 12. Eur J Cancer. 2007. PMID: 17223540
Clinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) study.
Gillio-Tos A, De Marco L, Carozzi FM, Del Mistro A, Girlando S, Burroni E, Frayle-Salamanca H, Giorgi Rossi P, Pierotti P, Ronco G; New Technologies for Cervical Cancer Screening Working Group. Gillio-Tos A, et al. J Clin Microbiol. 2013 Sep;51(9):2901-7. doi: 10.1128/JCM.01047-13. Epub 2013 Jun 26. J Clin Microbiol. 2013. PMID: 23804385 Free PMC article. Clinical Trial.
The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment.
Ronco G, Brezzi S, Carozzi F, Dalla Palma P, Giorgi-Rossi P, Minucci D, Naldoni C, Segnan N, Zappa M, Zorzi M, Cuzick J; NTCC study group. Ronco G, et al. Among authors: brezzi s. Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S230-2. doi: 10.1016/j.ygyno.2007.07.021. Epub 2007 Sep 6. Gynecol Oncol. 2007. PMID: 17822751 Clinical Trial.
Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.
Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, De Marco L, Giorgi-Rossi P, Pontenani G, Rosso S, Sani C, Sintoni C, Segnan N, Zorzi M, Cuzick J, Rizzolo R, Ronco G; New Technologies for Cervival Cancer Screening (NTCC) Working Group. Carozzi F, et al. Lancet Oncol. 2008 Oct;9(10):937-45. doi: 10.1016/S1470-2045(08)70208-0. Epub 2008 Sep 8. Lancet Oncol. 2008. PMID: 18783988 Clinical Trial.
A cross-sectional study to estimate high-risk human papillomavirus prevalence and type distribution in Italian women aged 18-26 years.
Giambi C, Donati S, Carozzi F, Salmaso S, Declich S, Atti ML, Ronco G, Alibrandi MP, Brezzi S, Collina N, Franchi D, Lattanzi A, Minna MC, Nannini R, Barretta E, Burroni E, Gillio-Tos A, Macallini V, Pierotti P, Bella A. Giambi C, et al. Among authors: brezzi s. BMC Infect Dis. 2013 Feb 7;13:74. doi: 10.1186/1471-2334-13-74. BMC Infect Dis. 2013. PMID: 23390953 Free PMC article.
13 results